Initial Management Approach for Acute Gastritis vs. Gastroenteritis
The initial management of acute gastritis differs from gastroenteritis primarily in that gastroenteritis requires focused rehydration therapy as first-line treatment, while gastritis typically requires acid suppression and mucosal protection. 1
Differential Diagnosis
Acute Gastritis
- Inflammation limited to the stomach lining
- Key symptoms:
- Epigastric pain/discomfort
- Nausea and vomiting
- Possible hematemesis
- Usually no diarrhea
- Normal vital signs unless significant bleeding occurs
Acute Gastroenteritis
- Inflammation affecting both stomach and intestines
- Key symptoms:
- Vomiting (typically occurs first)
- Diarrhea (develops within 24 hours)
- Abdominal cramping
- Possible fever
- Signs of dehydration based on severity
Management Approach for Acute Gastritis
Identify and remove triggering factors:
- Discontinue NSAIDs, alcohol, or other gastric irritants
- Consider H. pylori testing if clinically indicated
Pharmacologic therapy:
- Proton pump inhibitors (first-line)
- H2 receptor antagonists (alternative)
- Antacids for immediate symptom relief
- Sucralfate for mucosal protection if needed
Supportive care:
- Mild diet modifications (avoid spicy/acidic foods)
- Small, frequent meals
- Adequate hydration
Special considerations:
- Endoscopy for patients with alarm symptoms (hematemesis, melena, weight loss)
- Antiemetics if vomiting is severe
Management Approach for Acute Gastroenteritis
Assess hydration status 1:
- Mild (3-5%): Increased thirst, slightly dry mucous membranes, normal vital signs
- Moderate (6-9%): Loss of skin turgor, skin tenting, dry mucous membranes, tachycardia
- Severe (≥10%): Lethargy, prolonged skin tenting, cool extremities, decreased capillary refill, hypotension
Rehydration therapy (primary intervention) 1:
Oral rehydration therapy (ORT) for mild to moderate dehydration:
- Adults: 2-4 L of oral rehydration solution (ORS)
- Children: 50-100 mL/kg over 3-4 hours
Intravenous fluids indicated for:
- Severe dehydration
- Shock
- Altered mental status
- Ileus
- Failure of ORT
- Use isotonic fluids (lactated Ringer's or normal saline)
- Ondansetron:
- Children >4 years: 0.15 mg/kg of orally dissolving tablet
- Adults: 4-8 mg orally
- Improves tolerance of oral rehydration
- Reduces need for IV fluids and hospitalization
- Ondansetron:
Nutritional approach 1:
- Early refeeding during or immediately after rehydration
- Continue breastfeeding throughout diarrheal episodes in infants
- Resume regular diet quickly (fasting for 24 hours is not beneficial)
Antimotility agents 1:
- Loperamide:
- Contraindicated in children <18 years
- May be used in immunocompetent adults with acute watery diarrhea
- Avoid in inflammatory diarrhea, bloody diarrhea, or fever
- Loperamide:
- Not routinely recommended
- Consider in specific situations:
- Infants <3 months with suspected bacterial etiology
- Immunocompromised patients with severe illness
- Patients with fever >38.5°C
- Recent international travel
- Signs of sepsis
- Confirmed bacterial pathogens requiring treatment
Special Considerations
Vulnerable populations 1:
- Very young and elderly patients are at higher risk of dehydration
- Closer monitoring required for signs of dehydration
Red flags requiring urgent attention:
- Severe abdominal pain
- Bloody diarrhea with high fever
- Signs of severe dehydration or shock
- Altered mental status
- Significant comorbidities
Prevention measures 1:
- Hand hygiene after using toilet, changing diapers, before/after food preparation
- Proper cleaning of environmental surfaces
- Appropriate food safety practices
Common Pitfalls to Avoid
- Overuse of antibiotics in viral gastroenteritis
- Underutilization of oral rehydration therapy despite its proven effectiveness
- Inappropriate use of antimotility agents in children or in inflammatory diarrhea
- Delaying refeeding which can prolong recovery
- Missing serious underlying conditions that present similarly to gastroenteritis
By following these evidence-based approaches, clinicians can effectively manage both acute gastritis and gastroenteritis while reducing complications, hospitalizations, and improving patient outcomes.